New CEO for Ultraceuticals

Ultraceuticals is proud to announce the appointment of Martin Dowling as C.E.O. of Ultraceuticals.


Ultraceuticals is Australia’s pre-eminent cosmeceutical skincare brand offering premium professional products and in-clinic treatments in the local market and internationally.

Martin Dowling has joined Ultraceuticals as the company’s C.E.O. Previously Martin was C.O.O. of Corporate Express Australia Limited and the C.E.O. of the Star Group of companies. Martin remains a Non-Executive Director of the Star Group. Martin is also a founding shareholder and Director of the business group for C.E.O.s, Coraggio.

According to Martin, “My role will be to build on the outstanding success that Ultraceuticals enjoys here and globally. Our company is full of highly skilled people who are committed to the business and its core values. Dr Geoffrey Heber has constructed a company with strong technologies and brand differentiation. We have a great organisation and are in the unique position where customer demand for our product outstrips the capacity of our current distribution network. Our main goal for Ultraceuticals is the expansion of our distribution network through “skin expert” orientated medical and aesthetician clinics in Australia and internationally.”

Dr. Geoffrey Heber said “I’m very pleased that Martin has accepted the position of C.E.O. at Ultraceuticals. I have known Martin for over 10 years and have always been impressed by his business insight and skills, in particular, his ability to successfully drive businesses into and during periods of high growth. Martin’s blend of skills will add considerably to Ultraceuticals strong product development and sales and marketing skills.”

Ultraceuticals Australian made cosmeceutical skincare is developed by our physician lead in-house R&D and is scientifically substantiated and rigorously tested on human skin for visible results. Only available and prescribed through a selective network of skin expert clinics.

Contact: Ultraceuticals 1800 355 890.

Leave a Reply

Back to top